Similarly, the frequencies of CD25+ Tcon cells remained equal between the two groups, despite the elevated percentage of Ki-67-expressing naïve Tcon cells found in treated MS patients (Figures S3A, C). Here, MKI67 is linked to myeloid sarcoma.